MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    A secretory vesicle failure in Parkinson’s disease occurs in human platelets

    P. Montenegro, M. Pueyo, JN. Lorenzo, R. González-Brito, A. Méndez, R. Borges (La Laguna, Spain)

    Objective: Since platelets use similar, if not the same, mechanisms to accumulate serotonin (5-HT) as dopaminergic neurons to store DA in their VS; we wonder…
  • 2022 International Congress

    Aquatic Physical Therapy: Effects on Functional Mobility in people with Parkinson’s Disease

    J. Siega, T. Christinelli, G. Leveck, A. Silva, V. Israel (CURITIBA, Brazil)

    Objective: Evaluate the effects of Aquatic Physical Therapy (APT) on the functional mobility of individuals with Parkinson's disease (PD). Background: PD is neurodegenerative, idiopathic, and…
  • 2022 International Congress

    IPX203 dose conversion from immediate-release carbidopa-levodopa, in Parkinson’s disease patients with motor fluctuations.

    R. Hauser, A. Espay, W. Ondo, B. Safirstein, H. Moore, R. Kumar, G. Banisadr, S. Fisher (Tampa, USA)

    Objective: To analyze dosing regimen data from a Phase 3 study in order to identify an optimal dose conversion from IR CD-LD to IPX203 for…
  • 2022 International Congress

    Functional Movement Disorder Comorbidity in Parkinson’s Disease: a Multicenter Descriptive Study in Spain

    C. Delgado, A. Lopez, E. Lopez, V. Gomez, A. Baltasar, JC. Martinez, A. Alonso, G. Tabar, PJ. Garcia, S. de Lafuente, L. Vela, I. Pareés, M. Kurtis (Madrid, Spain)

    Objective: To describe clinical and demographic characteristics of a Spanish cohort with Parkinson's Disease (PD) and Functional Movement Disorder (FMD) comorbidity. Background: Functional overlay in…
  • 2022 International Congress

    Patient-specific multivariate gray matter volumetric distance to predict disease severity in Parkinson’s disease

    A. Vijayakumari, H. Fernandez, B. Walter (Cleveland, USA)

    Objective: Identifying novel biomarkers to predict disease progression is of paramount importance in patients with Parkinson’s disease (PD). In this study, we utilized Structural Magnetic…
  • 2022 International Congress

    Outcomes of surgical management of pelvic floor dysfunction in women with Parkinson’s disease

    D. Mohanty, A. Gupta, D. Sheyn, J. Gaskins, A. Mahajan (Louisville, USA)

    Objective: To assess the effect of Parkinson’s disease (PD) on outcomes of surgical management in women with pelvic floor dysfunction (PFD). Background: PFD is more…
  • 2022 International Congress

    Long-term wearable tele-rehabilitation of gait for persons with Parkinson’s disease: A feasibility study

    G. Lopane, M. Corzani, I. D'Ascanio, V. Petrone, M. Contin, G. Calandra Buonaura, P. Cortelli, F. La Porta, M. Brozgol, N. Giladi, PC. Thumm, JM. Hausdorff, L. Chiari, L. Palmerini (Bologna, Italy)

    Objective: This study aims to evaluate the feasibility of long-term wearable tele-rehabilitation of gait in people with Parkinson’s disease. Background: Tele-rehabilitation allows patients to utilize…
  • 2022 International Congress

    Caregiving patients with Parkinson disease treated with deep brain stimulation: a systematic review and meta-synthesis of qualitative research

    V. Fioravanti, F. Cavallieri, F. Sireci, M. Parmeggiani, C. Pedroni, F. Mardones, M. Bassi, E. Moro, L. Ghirotto, F. Valzania (Reggio Emilia, Italy)

    Objective: To explore the experiences and unmet needs of Parkinson disease patients (PDPs) caregivers after subthalamic nucleus deep brain stimulation (STN-DBS) by performing a systematic…
  • 2022 International Congress

    Evoked resonant neural activity within the dorsolateral subthalamic nucleus as a biomarker for the targeting of deep brain stimulation for Parkinson’s disease

    H. Simpson, S. Xu, W. Lee, A. Begg, K. Bulluss, H. Mcdermott, W. Thevathasan, T. Perera (Melbourne, Australia)

    Objective: The objective of the study was to determine the anatomical localisation of evoked resonant neural activity (ERNA), which is being investigated as a potential…
  • 2022 International Congress

    Apomorphine sublingual film patient-reported motor status response at home throughout the day

    J. Obeso, K. Chaudhuri, R. Hauser, G. Jones, G. Castilla-Fernández, D. Magalhães (Madrid, Spain)

    Objective: To assess the efficacy throughout the day of self-administered apomorphine sublingual film (SL-APO) compared with placebo (PLC) for the treatment of OFF episodes in…
  • « Previous Page
  • 1
  • …
  • 324
  • 325
  • 326
  • 327
  • 328
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley